Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease.
about
Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to studentsCommentary: Evaluation of Models of Parkinson's DiseaseSeverely impaired hippocampal neurogenesis associates with an early serotonergic deficit in a BAC α-synuclein transgenic rat model of Parkinson's disease.Infiltrating T lymphocytes reduce myeloid phagocytosis activity in synucleinopathy model.Amphetamine Withdrawal Differentially Increases the Expression of Organic Cation Transporter 3 and Serotonin Transporter in Limbic Brain Regions.MicroRNA expressing profiles in A53T mutant alpha-synuclein transgenic mice and Parkinsonian.What Gene Mutations Affect Serotonin in Mice?Synaptic signalling and its interface with neuropathologies: snapshots from the past, present and future.Early Degeneration of Both Dopaminergic and Serotonergic Axons - A Common Mechanism in Parkinson's Disease.Commentary: Clinical Correlates of Raphe Serotonergic Dysfunction in Early Parkinson's Disease.A Protein Aggregation Inhibitor, Leuco-Methylthioninium Bis(Hydromethanesulfonate), Decreases α-Synuclein Inclusions in a Transgenic Mouse Model of Synucleinopathy.Prenatal androgen receptor activation determines adult alcohol and water drinking in a sex-specific way.Parkinson's disease, anxious depression and serotonin--zooming in on hippocampal neurogenesis.[Cellular replacement strategies and adult neurogenesis in idiopathic Parkinson's disease].Neuronal replacement therapy: previous achievements and challenges ahead.Acetylome in Human Fibroblasts From Parkinson's Disease Patients.Investigation of Behavioral Dysfunctions Induced by Monoamine Depletions in a Mouse Model of Parkinson's Disease
P2860
Q28077671-BBACFD26-7CF9-42F3-A4B7-BF050B13683AQ28397369-30FAB767-1686-4457-8227-C83A0CCF5438Q30795299-52DA87B5-9162-454F-9478-E728EA3261F2Q37057806-7A4A8166-3B87-499D-9E66-B23EF1FF7D19Q37118753-35F07093-B6FD-4B5D-964F-508560F43AD2Q37702119-EA74360C-DD98-4D50-A9ED-F88C7C644959Q38434699-0303A02A-8B3C-442D-9E5D-1ED53765EC88Q38802640-E196A0AE-53DB-47D4-A713-4FBE7EBCBD5FQ39075710-CE69EC6B-BA0A-4C07-9B28-5380F8B85C76Q43122361-1D0357D7-2510-4DF3-9D57-4AD0054763C5Q47548619-DFA1189F-A891-4ED6-848B-6EEF123A9CACQ47942495-B1A98D16-C2EB-4FA9-BE04-799CF4CE6447Q48074568-43EF2E7A-F53E-440F-8E5E-FFEB656F8AF9Q50242092-BA92C13F-36AF-48AC-ABF8-FDC844D2F725Q52729618-B3893543-97FF-4F8F-9CF2-81F9EC65AFFFQ54112963-31E85BEE-9F2B-40E6-AA7A-DAEF1C31ED74Q58795485-DEAFA5D8-EF00-4862-986C-EB1AC84FC76D
P2860
Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 July 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease.
@en
Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease.
@nl
type
label
Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease.
@en
Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease.
@nl
prefLabel
Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease.
@en
Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease.
@nl
P2093
P2860
P356
P1476
Serotonergic dysfunction in the A53T alpha-synuclein mouse model of Parkinson's disease.
@en
P2093
Christian P Müller
Janina Deusser
Jürgen Winkler
Sabine Huber
Sonja Plötz
Stefanie Schmidt
Zacharias Kohl
P2860
P304
P356
10.1111/JNC.13253
P407
P577
2015-07-23T00:00:00Z